![]() | Only 14 pages are availabe for public view |
Abstract The risk to benefit ratio of thrombolytic therapy in patients with inferior AMI continues to be controversial IT has been suggested that only patients with inferior AMI presenting larger ST srgment deviations would benefit from thrombolytic therapy. |